New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Older women with breast cancer may benefit from genetic testing, study suggests

Older women with breast cancer may benefit from genetic testing, study suggests

byStanford University Medical CenterCredit: CC0 Public DomainAbout 1 in 40 postmenopausal women diagnosed with breast cancer before age 65 have cancer-associated mutations in their BRCA1 or BRCA
World medicine December 11,2023
Older women with breast cancer may benefit from genetic testing, study suggests

Older women with breast cancer may benefit from genetic testing, study suggests

byStanford University Medical CenterCredit: CC0 Public DomainAbout 1 in 40 postmenopausal women diagnosed with breast cancer before age 65 have cancer-associated mutations in their BRCA1 or BRCA
World medicine December 11,2023
Cancer death rates continue to fall in U.S., report says

Cancer death rates continue to fall in U.S., report says

(HealthDay)—U.S. death rates from cancer continued falling from 2001 to 2017—dropping an average 1.5% a year, a new report shows.The annual decline was slightly larger among men (1.8%) than women (1.4
World medicine December 11,2023
Cancer death rates continue to fall in U.S., report says

Cancer death rates continue to fall in U.S., report says

(HealthDay)—U.S. death rates from cancer continued falling from 2001 to 2017—dropping an average 1.5% a year, a new report shows.The annual decline was slightly larger among men (1.8%) than women (1.4
World medicine December 11,2023
Surveillance after surgery does not improve outcomes for patients with glioblastoma

Surveillance after surgery does not improve outcomes for patients with glioblastoma

byUniversity of MissouriN. Scott Litofsky, M.D. Credit: MU Health CareGlioblastoma is an aggressive and deadly brain cancer. Although improved treatment protocols have doubled the survival rate
World medicine December 11,2023
Surveillance after surgery does not improve outcomes for patients with glioblastoma

Surveillance after surgery does not improve outcomes for patients with glioblastoma

byUniversity of MissouriN. Scott Litofsky, M.D. Credit: MU Health CareGlioblastoma is an aggressive and deadly brain cancer. Although improved treatment protocols have doubled the survival rate
World medicine December 11,2023
A new strategy to prevent the most aggressive tumors from generating resistance to chemotherapy

A new strategy to prevent the most aggressive tumors from generating resistance to chemotherapy

byThe Spanish National Cancer Research CentrePancreatic adenocarcinoma tumor cells showing signs of damage in the DNA of the nucleus (white dots) and micronuclei (in green), after treatment with
World medicine December 11,2023
A new strategy to prevent the most aggressive tumors from generating resistance to chemotherapy

A new strategy to prevent the most aggressive tumors from generating resistance to chemotherapy

byThe Spanish National Cancer Research CentrePancreatic adenocarcinoma tumor cells showing signs of damage in the DNA of the nucleus (white dots) and micronuclei (in green), after treatment with
World medicine December 11,2023
Chemotherapy after surgery halves risk of rare kidney cancer coming back

Chemotherapy after surgery halves risk of rare kidney cancer coming back

by Sarah Wells,Institute of Cancer ResearchCredit: CC0 Public DomainChemotherapy halves the risk of a rare form of kidney cancer coming back after surgery, the largest ever trial conducted in th
World medicine December 11,2023
Chemotherapy after surgery halves risk of rare kidney cancer coming back

Chemotherapy after surgery halves risk of rare kidney cancer coming back

by Sarah Wells,Institute of Cancer ResearchCredit: CC0 Public DomainChemotherapy halves the risk of a rare form of kidney cancer coming back after surgery, the largest ever trial conducted in th
World medicine December 11,2023
Scientists develop free computer program to map blood flow 'landscape' in tumors

Scientists develop free computer program to map blood flow 'landscape' in tumors

byJohns Hopkins University School of MedicineJohns Hopkins Medicine researchers have created a computer program for scientists at no charge that lets users readily quantify the structural and fu
World medicine December 11,2023
Scientists develop free computer program to map blood flow 'landscape' in tumors

Scientists develop free computer program to map blood flow 'landscape' in tumors

byJohns Hopkins University School of MedicineJohns Hopkins Medicine researchers have created a computer program for scientists at no charge that lets users readily quantify the structural and fu
World medicine December 11,2023
Immunotherapy combo effective for patients with high-grade neuroendocrine cancer

Immunotherapy combo effective for patients with high-grade neuroendocrine cancer

by SWOGMany patients with rare, fast-growing neuroendocrine tumors respond well to a common immunotherapy drug combination, according to the first peer-reviewed publication out of DART, short for Dual
World medicine December 11,2023
Immunotherapy combo effective for patients with high-grade neuroendocrine cancer

Immunotherapy combo effective for patients with high-grade neuroendocrine cancer

by SWOGMany patients with rare, fast-growing neuroendocrine tumors respond well to a common immunotherapy drug combination, according to the first peer-reviewed publication out of DART, short for Dual
World medicine December 11,2023
Dramatic increase in bowel cancer in young adults in England

Dramatic increase in bowel cancer in young adults in England

byUniversity of BristolCredit: CC0 Public DomainThere has been a dramatic increase in the incidence of bowel cancer in adults under the age of 50, according to new research from the University o
World medicine December 11,2023
Dramatic increase in bowel cancer in young adults in England

Dramatic increase in bowel cancer in young adults in England

byUniversity of BristolCredit: CC0 Public DomainThere has been a dramatic increase in the incidence of bowel cancer in adults under the age of 50, according to new research from the University o
World medicine December 11,2023
African Americans, Hispanics less likely to receive recommended lung cancer imaging

African Americans, Hispanics less likely to receive recommended lung cancer imaging

byCU Anschutz Medical CampusRustain Morgan and colleagues show racial/ethnic disparities in use of important imaging during lung cancer diagnosis Credit: University of Colorado Cancer CenterThe
World medicine December 11,2023
African Americans, Hispanics less likely to receive recommended lung cancer imaging

African Americans, Hispanics less likely to receive recommended lung cancer imaging

byCU Anschutz Medical CampusRustain Morgan and colleagues show racial/ethnic disparities in use of important imaging during lung cancer diagnosis Credit: University of Colorado Cancer CenterThe
World medicine December 11,2023
Use of PPIs tied to cognitive issues in breast cancer survivors

Use of PPIs tied to cognitive issues in breast cancer survivors

(HealthDay)—Use of acid reflux drugs (proton pump inhibitors [PPIs]) during and after cancer treatment may be tied to impaired memory and concentration in breast cancer survivors, according to a study
World medicine December 11,2023
Use of PPIs tied to cognitive issues in breast cancer survivors

Use of PPIs tied to cognitive issues in breast cancer survivors

(HealthDay)—Use of acid reflux drugs (proton pump inhibitors [PPIs]) during and after cancer treatment may be tied to impaired memory and concentration in breast cancer survivors, according to a study
World medicine December 11,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com